MAPK1 and carcinoma: Serum stimulation activated MAPK equally well in primary and carcinoma cell lines, which is most apparent in the robust amount of phosphorylated ERK (p-ERK) detected in both breast (Figure 1A) and ovarian (Figure 1B) epithelial cells.